This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Pacemakers/ Defibrillators  • Quality of Life  • Women's Health, Other  • Prognosis/ Outcomes  • Cardiovascular Intervention  • Alert me on articles by topic

Moving Beyond Process Measures to Outcomes Data

Rita F. Redberg, MD, MSc

JAMA. 2007;298:1564-1566.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In recent years, significant disparities have been increasingly recognized among different patient populations in the health care system—disparities that largely mirror those in other aspects of society. An Institute of Medicine report from 2002 highlighted these disparities, finding that a consistent body of research shows substantial variations in the rates of medical procedures by race/ethnicity, even when insurance status, income, age, and severity of conditions are comparable.¹ Moreover, it has been known for many years that women and racial/ethnic minorities are less likely to be offered procedures such as cardiac catheterization, coronary artery bypass graft surgery, and carotid endarterectomy.^2-4

Implantable cardioverter-defibrillators (ICDs), first introduced about 20 years ago, are widely recognized as a potentially lifesaving therapy for those at highest risk for sudden cardiac death. The use of ICDs has increased steadily since the results of 2 clinical trials—the Multicenter Automatic Defibrillator Implantation Study (MADIT-II)⁵ . . . [Full Text of this Article]

Author Affiliation: Women's Cardiovascular Services, University of California-San Francisco Division of Cardiology, School of Medicine, Division of Cardiology, San Francisco, California.

RELATED LETTERS

Predicting Benefit for Implantable Cardioverter-Defibrillator Use
Elsayed Z. Soliman
JAMA. 2008;299(3):286-287.
EXTRACT | FULL TEXT  

Predicting Benefit for Implantable Cardioverter-Defibrillator Use—Reply
Rita F. Redberg
JAMA. 2008;299(3):287.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death
Lesley H. Curtis, Sana M. Al-Khatib, Alisa M. Shea, Bradley G. Hammill, Adrian F. Hernandez, and Kevin A. Schulman
JAMA. 2007;298(13):1517-1524.
ABSTRACT | FULL TEXT  

Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart Failure
Adrian F. Hernandez, Gregg C. Fonarow, Li Liang, Sana M. Al-Khatib, Lesley H. Curtis, Kenneth A. LaBresh, Clyde W. Yancy, Nancy M. Albert, and Eric D. Peterson
JAMA. 2007;298(13):1525-1532.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predicting Benefit for Implantable Cardioverter-Defibrillator Use
Soliman
JAMA 2008;299:286-287.
FULL TEXT  

Sex, Race, and Implantable Cardioverter-Defibrillators
Journal Watch Cardiology 2007;2007:4-4.
FULL TEXT